Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stinker

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jul 23, 2024 1:18pm

70 Views

Post# 36144610

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stinker

Another excellent post. But you're kidding yourself if you think Republicans are the party of the people.

If both parties have contributed to the downfall, they have, why do you think DT will break from that tradition to enact policies to benefit anyone but the 1%?

He is looking to appoint people like Fink, Thiel and Dimon to his cabinet. This isn't a difficult one!

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023